According to IGM Biosciences's latest financial reports the company has a price-to-book ratio of 2.74.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.39 | -5.85% |
2022-12-31 | 2.54 | -34.84% |
2021-12-31 | 3.89 | -47.36% |
2020-12-31 | 7.39 | 52.68% |
2019-12-31 | 4.84 | |
2018-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.86 | 4.51% | ๐บ๐ธ USA |